PL2222291T3 - Związki do selektywnego leczenia jelitowego składnika immunozapalnego celiakii - Google Patents

Związki do selektywnego leczenia jelitowego składnika immunozapalnego celiakii

Info

Publication number: PL2222291T3
Authority: PL; Poland
Prior art keywords: celiac disease; compounds; inflammatory component; immuno; intestinal
Prior art date: 2007-12-24

Application number

PL08863709T

Other languages

English (en)

Inventor

Sergio Baroni

Salvatore Bellinvia

Original Assignee

Giuliani International Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-24

Filing date

2008-12-23

Publication date

2012-08-31

2008-12-23 Application filed by Giuliani International Ltd filed Critical Giuliani International Ltd

2012-08-31 Publication of PL2222291T3 publication Critical patent/PL2222291T3/pl

Links

208000015943 Coeliac disease Diseases 0.000 title abstract 4
150000001875 compounds Chemical class 0.000 title abstract 3
230000000495 immunoinflammatory effect Effects 0.000 title 1
230000000968 intestinal effect Effects 0.000 title 1
235000005911 diet Nutrition 0.000 abstract 2
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 abstract 1
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
230000000903 blocking effect Effects 0.000 abstract 1
230000037213 diet Effects 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Furan Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL08863709T 2007-12-24 2008-12-23 Związki do selektywnego leczenia jelitowego składnika immunozapalnego celiakii PL2222291T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IT002429A ITMI20072429A1 (it)	2007-12-24	2007-12-24	Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
EP08863709A EP2222291B1 (en)	2007-12-24	2008-12-23	Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
PCT/EP2008/068265 WO2009080828A2 (en)	2007-12-24	2008-12-23	Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease

Publications (1)

Publication Number	Publication Date
PL2222291T3 true PL2222291T3 (pl)	2012-08-31

Family

ID=40315657

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08863709T PL2222291T3 (pl)	2007-12-24	2008-12-23	Związki do selektywnego leczenia jelitowego składnika immunozapalnego celiakii

Country Status (23)

Country	Link
US (2)	US8153693B2 (pl)
EP (2)	EP2279733A3 (pl)
JP (1)	JP2011507818A (pl)
KR (1)	KR20100103836A (pl)
CN (2)	CN101969943A (pl)
AT (1)	ATE550020T1 (pl)
AU (1)	AU2008339909A1 (pl)
BR (1)	BRPI0821331A2 (pl)
CA (1)	CA2708512A1 (pl)
CY (1)	CY1112821T1 (pl)
DK (1)	DK2222291T3 (pl)
EA (1)	EA201001058A1 (pl)
ES (1)	ES2384361T3 (pl)
HR (1)	HRP20120404T1 (pl)
IL (1)	IL206226A0 (pl)
IT (1)	ITMI20072429A1 (pl)
MX (1)	MX2010007033A (pl)
NZ (1)	NZ586191A (pl)
PL (1)	PL2222291T3 (pl)
PT (1)	PT2222291E (pl)
SI (1)	SI2222291T1 (pl)
WO (1)	WO2009080828A2 (pl)
ZA (1)	ZA201004802B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2359812C (en)	2000-11-20	2004-02-10	The Procter & Gamble Company	Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) *	2008-12-05	2015-01-26		Спосіб лікування псоріазу
WO2010091894A2 (en)	2009-02-16	2010-08-19	Giuliani International Limited	Methods of treating hair related conditions
CN103153944A (zh) *	2010-09-10	2013-06-12	法莫再尔公司	晶态5-氨基水杨酸的制备方法
CN109999017A (zh)	2012-02-09	2019-07-12	诺格拉制药有限公司	治疗纤维化的方法
CN104284655B (zh)	2012-04-18	2017-10-27	诺格拉制药有限公司	治疗乳糖不耐受的方法
WO2019164874A1 (en) *	2018-02-20	2019-08-29	Western New England University	Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases
EP4495101A3 (en)	2019-02-08	2025-04-30	Nogra Pharma Limited	Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN113801126A (zh) *	2021-07-20	2021-12-17	云南大学	一种多取代吡啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1313697T3 (da) *	2000-08-29	2006-04-10	Nobex Corp	Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
AU2004314731B2 (en)	2004-01-20	2011-07-07	The Board Of Regents Of The University Of Oklahoma	Compositions and methods of treatment for inflammatory diseases
US20060270635A1 (en) *	2005-05-27	2006-11-30	Wallace John L	Derivatives of 4- or 5-aminosalicylic acid
WO2006125293A1 (en) *	2005-05-27	2006-11-30	Antibe Therapeutics Inc.	Derivatives of 4- or 5-aminosalicylic acid
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) *	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

2007
- 2007-12-24 IT IT002429A patent/ITMI20072429A1/it unknown
2008
- 2008-12-23 SI SI200830659T patent/SI2222291T1/sl unknown
- 2008-12-23 CN CN2008801225541A patent/CN101969943A/zh active Pending
- 2008-12-23 HR HRP20120404AT patent/HRP20120404T1/hr unknown
- 2008-12-23 NZ NZ586191A patent/NZ586191A/en not_active IP Right Cessation
- 2008-12-23 EP EP10188940A patent/EP2279733A3/en not_active Withdrawn
- 2008-12-23 CA CA2708512A patent/CA2708512A1/en not_active Abandoned
- 2008-12-23 JP JP2010538801A patent/JP2011507818A/ja active Pending
- 2008-12-23 ES ES08863709T patent/ES2384361T3/es active Active
- 2008-12-23 AT AT08863709T patent/ATE550020T1/de active
- 2008-12-23 EA EA201001058A patent/EA201001058A1/ru unknown
- 2008-12-23 EP EP08863709A patent/EP2222291B1/en not_active Not-in-force
- 2008-12-23 KR KR1020107016082A patent/KR20100103836A/ko not_active Withdrawn
- 2008-12-23 PL PL08863709T patent/PL2222291T3/pl unknown
- 2008-12-23 BR BRPI0821331-3A patent/BRPI0821331A2/pt not_active IP Right Cessation
- 2008-12-23 US US12/810,159 patent/US8153693B2/en not_active Expired - Fee Related
- 2008-12-23 CN CN2011103980277A patent/CN102641279A/zh active Pending
- 2008-12-23 DK DK08863709.5T patent/DK2222291T3/da active
- 2008-12-23 MX MX2010007033A patent/MX2010007033A/es active IP Right Grant
- 2008-12-23 PT PT08863709T patent/PT2222291E/pt unknown
- 2008-12-23 AU AU2008339909A patent/AU2008339909A1/en not_active Abandoned
- 2008-12-23 WO PCT/EP2008/068265 patent/WO2009080828A2/en not_active Ceased
2010
- 2010-06-07 IL IL206226A patent/IL206226A0/en unknown
- 2010-07-07 ZA ZA2010/04802A patent/ZA201004802B/en unknown
2011
- 2011-12-20 US US13/331,173 patent/US20120157417A1/en not_active Abandoned
2012
- 2012-06-06 CY CY20121100511T patent/CY1112821T1/el unknown

Also Published As

Publication number	Publication date
EP2279733A2 (en)	2011-02-02
IL206226A0 (en)	2010-12-30
JP2011507818A (ja)	2011-03-10
ATE550020T1 (de)	2012-04-15
US8153693B2 (en)	2012-04-10
WO2009080828A3 (en)	2009-10-01
DK2222291T3 (da)	2012-06-25
HRP20120404T1 (hr)	2012-06-30
US20100305077A1 (en)	2010-12-02
BRPI0821331A2 (pt)	2015-06-16
US20120157417A1 (en)	2012-06-21
EP2222291A2 (en)	2010-09-01
EA201001058A1 (ru)	2011-02-28
CN102641279A (zh)	2012-08-22
SI2222291T1 (sl)	2012-08-31
CA2708512A1 (en)	2009-07-02
ZA201004802B (en)	2011-03-30
AU2008339909A1 (en)	2009-07-02
EP2279733A3 (en)	2011-03-23
CN101969943A (zh)	2011-02-09
KR20100103836A (ko)	2010-09-28
ES2384361T3 (es)	2012-07-04
ITMI20072429A1 (it)	2009-06-25
NZ586191A (en)	2012-06-29
PT2222291E (pt)	2012-07-02
WO2009080828A2 (en)	2009-07-02
EP2222291B1 (en)	2012-03-21
MX2010007033A (es)	2010-10-07
CY1112821T1 (el)	2016-02-10

Publication	Publication Date	Title
IL206226A0 (en)	2010-12-30	Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
UA89812C2 (ru)	2010-03-10	Замещенные пиридинильные и пиримидинильные производные, которые применяют как модуляторы метаболизма и для лечения ассоциированных с ним расстройств
TW200610528A (en)	2006-04-01	Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
IL191832A0 (en)	2008-12-29	Pyridiazinone derivatives for the treatment of tumours
EP2298304A3 (en)	2011-10-12	Carboline derivatives useful in the treatment of cancer
PT2638812T (pt)	2018-05-15	Composição para estimular a flora intestinal de lactentes nascidos por cesariana
IL188847A0 (en)	2008-04-13	Nutrition for obese patients
PL2247602T3 (pl)	2013-08-30	Pochodne O-glukuronido-adamantylowe jako inhibitory dipeptydylopeptydazy IV do leczenia cukrzycy
MX2010003365A (es)	2010-04-30	Derivados de tiazol para el tratamiento de cancer.
WO2007144057A3 (en)	2008-11-06	Antimicrobial carbon
IL198912A0 (en)	2010-02-17	Isosorbide mononitrate derivatives for the treatment of intestinal disorders
EP1979487A4 (en)	2010-05-05	COBALAMINE COMPOSITIONS FOR THE TREATMENT OF CANCER
PL2036526T3 (pl)	2013-11-29	Wózek transportowy dla leżyska dla pacjenta stołu operacyjnego
IL201451A0 (en)	2010-05-31	Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of spinal cord traumas
WO2006125815A3 (en)	2007-04-26	Tetrahydropyridothiophenes for use in the treatment of cancer
GB0517387D0 (en)	2005-10-05	Combinations for the treatment of cancer
IL201447A0 (en)	2010-05-31	Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of cranial traumas
GB0517386D0 (en)	2005-10-05	Combinations for the treatment of cancer
ZA200802347B (en)	2009-09-30	Nutrition for obese patients
ZA200803101B (en)	2009-03-25	4-oxadiozolyl-piperidine compounds and use thereof
HU3015U (en)	2005-11-28	Apparatus for treatment with gas
AU2005900309A0 (en)	2005-02-10	Combination Therapy for Treatment of Neoplasia (Capecitabine)
IL189802A0 (en)	2008-11-03	Compounds for improving nutritional status, cognition and survival